Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

GRAIL, Inc.

GRALNASDAQ
Healthcare
Medical - Diagnostics & Research
$43.03
$-7.18(-14.30%)
U.S. Market opens in 14h 1m

GRAIL, Inc. Fundamental Analysis

GRAIL, Inc. (GRAL) shows moderate financial fundamentals with a PE ratio of -4.26, profit margin of -2.77%, and ROE of -17.11%. The company generates $0.1B in annual revenue with strong year-over-year growth of 17.18%.

Key Strengths

Cash Position51.61%
PEG Ratio-1.10
Current Ratio11.97

Areas of Concern

ROE-17.11%
Operating Margin-3.63%
We analyze GRAL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -189.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-189.3/100

We analyze GRAL's fundamental strength across five key dimensions:

Efficiency Score

Weak

GRAL struggles to generate sufficient returns from assets.

ROA > 10%
-13.97%

Valuation Score

Excellent

GRAL trades at attractive valuation levels.

PE < 25
-4.26
PEG Ratio < 2
-1.10

Growth Score

Excellent

GRAL delivers strong and consistent growth momentum.

Revenue Growth > 5%
17.18%
EPS Growth > 10%
82.51%

Financial Health Score

Excellent

GRAL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
11.97

Profitability Score

Weak

GRAL struggles to sustain strong margins.

ROE > 15%
-1711.06%
Net Margin ≥ 15%
-2.77%
Positive Free Cash Flow
No

Key Financial Metrics

Is GRAL Expensive or Cheap?

P/E Ratio

GRAL trades at -4.26 times earnings. This suggests potential undervaluation.

-4.26

PEG Ratio

When adjusting for growth, GRAL's PEG of -1.10 indicates potential undervaluation.

-1.10

Price to Book

The market values GRAIL, Inc. at 0.68 times its book value. This may indicate undervaluation.

0.68

EV/EBITDA

Enterprise value stands at -4.54 times EBITDA. This is generally considered low.

-4.54

How Well Does GRAL Make Money?

Net Profit Margin

For every $100 in sales, GRAIL, Inc. keeps $-2.77 as profit after all expenses.

-2.77%

Operating Margin

Core operations generate -3.63 in profit for every $100 in revenue, before interest and taxes.

-3.63%

ROE

Management delivers $-17.11 in profit for every $100 of shareholder equity.

-17.11%

ROA

GRAIL, Inc. generates $-13.97 in profit for every $100 in assets, demonstrating efficient asset deployment.

-13.97%

Following the Money - Real Cash Generation

Operating Cash Flow

GRAIL, Inc. generates limited operating cash flow of $-286.21M, signaling weaker underlying cash strength.

$-286.21M

Free Cash Flow

GRAIL, Inc. generates weak or negative free cash flow of $-286.21M, restricting financial flexibility.

$-286.21M

FCF Per Share

Each share generates $-7.34 in free cash annually.

$-7.34

FCF Yield

GRAL converts -17.78% of its market value into free cash.

-17.78%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.26

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.10

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.68

vs 25 benchmark

P/S Ratio

Price to sales ratio

11.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

11.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.17

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How GRAL Stacks Against Its Sector Peers

MetricGRAL ValueSector AveragePerformance
P/E Ratio-4.2629.28 Better (Cheaper)
ROE-17.11%820.00% Weak
Net Margin-277.47%-19743.00% (disorted) Weak
Debt/Equity0.020.26 Strong (Low Leverage)
Current Ratio11.974.69 Strong Liquidity
ROA-13.97%-17807.00% (disorted) Weak

GRAL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews GRAIL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-340.16%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-333.65%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ